PEPTONIC medical AB (XSAT:PMED) EPS (Basic): kr-0.00 (TTM As of Mar. 2026)


What is PEPTONIC medical AB EPS (Basic)?

PEPTONIC medical AB XSAT:PMED -25.00% EPS (Basic) is kr-0.00 as of Mar. 2026. The stock has 6 warning signs investors should review.

PEPTONIC medical AB's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was kr-0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.00.

PEPTONIC medical AB's EPS (Diluted) for the three months ended in Mar. 2026 was kr-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.00.

PEPTONIC medical AB's EPS without NRI for the three months ended in Mar. 2026 was kr-0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.00.

During the past 3 years, the average EPS without NRI Growth Rate was 67.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 55.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was 29.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, PEPTONIC medical AB's highest 3-Year average EPS without NRI Growth Rate was 67.30% per year. The lowest was -38.50% per year. And the median was 18.60% per year.

PEPTONIC medical AB  (XSAT:PMED) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

PEPTONIC medical AB EPS (Basic) Related Terms

PEPTONIC medical AB EPS (Basic) Historical Data

* Premium members only.

The historical data trend for PEPTONIC medical AB's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PEPTONIC medical AB EPS (Basic) Chart

PEPTONIC medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.15 -0.06 -0.02 -0.01 -0.00

PEPTONIC medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 -0.00 0.00 -0.00

PEPTONIC medical AB EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

PEPTONIC medical AB's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-22.495-0)/11642.942
=-0.00

PEPTONIC medical AB's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-5.684-0)/20724.567
=-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of kr-0.00 mean?
PEPTONIC medical AB (XSAT:PMED) has a EPS (Basic) of kr-0.00 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on PEPTONIC medical AB and its competitors.
Is PEPTONIC medical AB's EPS (Basic) too high?
PEPTONIC medical AB's current EPS (Basic) is kr-0.00.
How does PEPTONIC medical AB's EPS (Basic) compare to ZTS and UTHR?
PEPTONIC medical AB's EPS (Basic) of kr-0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on PEPTONIC medical AB and its competitors. PEPTONIC medical AB's current EPS (Basic) is kr-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PEPTONIC medical AB stock overvalued right now?
PEPTONIC medical AB (XSAT:PMED) has a current EPS (Basic) of kr-0.00. The current EPS (Basic) is kr-0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For PEPTONIC medical AB (XSAT:PMED), the current EPS (Basic) is kr-0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PEPTONIC medical AB Business Description

Address Gustavslundsvagen 143, Bromma, SWE, SE-167 51
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.